Cargando…
A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease
In the current study, for the first time, we study mitophagy enhancer urolithin A and a combination of urolithin A+green tea extract EGCG against human Aβ peptide-induced mitochondrial and synaptic, dendritic, inflammatory toxicities and behavioral changes in humanized homozygous amyloid beta knocki...
Autores principales: | Kshirsagar, Sudhir, Alvir, Rainier Vladlen, Pradeepkiran, Jangampalli Adi, Hindle, Ashly, Vijayan, Murali, Ramasubramaniam, Bhagavathi, Kumar, Subodh, Reddy, Arubala P., Reddy, P. Hemachandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454743/ https://www.ncbi.nlm.nih.gov/pubmed/36078067 http://dx.doi.org/10.3390/cells11172660 |
Ejemplares similares
-
Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer’s Disease
por: Kshirsagar, Sudhir, et al.
Publicado: (2022) -
A partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in a transgenic Tau mouse model
por: Vijayan, Murali, et al.
Publicado: (2022) -
Are mitophagy enhancers therapeutic targets for Alzheimer’s disease?
por: Pradeepkiran, Jangampalli Adi, et al.
Publicado: (2022) -
Rlip Reduction Induces Oxidative Stress and Mitochondrial Dysfunction in Mutant Tau-Expressed Immortalized Hippocampal Neurons: Mechanistic Insights
por: Reddy, P. Hemachandra, et al.
Publicado: (2023) -
Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease?
por: Hindle, Ashly, et al.
Publicado: (2022)